Consultant Pulmonary and CCM Professor of Medicine College of Medicine, Mayo Clinic
Pulmonology
Dr. David E. Midthun, MD
|
|
Give Review
David Midthun is an expert in the field of Pulmonology. He went to medical school at University of Minnesota Medical School. University of Minnesota Medical School is ranked 40/10 in Research/PrimaryCare. He received awards:"Fellow (FACP)". David Midthun has written publications. He has 66 publications published with PubMed. The lastest paper is: 'Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.' He accepts Medicare.
Publications
- Trends in Subpopulations at High Risk for Lung Cancer.
- Validation of a multiprotein plasma classifier to identify benign Lung nodules.
- Trends in the proportion of patients with Lung cancer meeting screening criteria.
- Screening for Lung cancer: The US studies.
- Evaluation of individuals with Pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidenc...
- Favorable Stage Distribution in the NELSON Trial.
- Randomized phase II trial of sulindac for Lung cancer chemoprevention.
- Quality of Life and Symptom Burden among Long-Term Lung Cancer Survivors.
- Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response.
- Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer.
- Screening for Lung Cancer: For Patients at Increased Risk for Lung Cancer, It Works.
- Effect of emphysema on Lung cancer risk in smokers: a computed tomography-based assessment.
- Are airflow obstruction and radiographic evidence of emphysema risk factors for Lung cancer? A nested case-control study using quantitative emphysema analysis.
- 5-year Lung cancer screening experience: growth curves of 18 Lung cancers compared to histologic type, CT attenuation, stage, survival, and size.
- Idiopathic nonspecific Interstitial pneumonia: report of an American Thoracic Society project.
- Update on screening for Lung cancer.
- Alpha1-antitrypsin deficiency carriers, tobacco smoke, Chronic obstructive pulmonary disease, and lung cancer risk.
- Commentary: CT screening for Lung cancer--caveat emptor.
- Primary salivary gland-type Lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors.
- A 39-year-old woman with cough, chest pressure, and worsening dyspnea.
- Nearly 90 degrees from normal.
- Five-year Lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 Lung cancers.
- Lung cancer screening results: easily misunderstood.
- Mediastinal lymphangioma: Mayo Clinic experience of 25 cases.
- Metastatic Lung cancer to the pancreas.
- Massive adrenal metastasis.
- Lung cancer screening experience: a retrospective review of PET in 22 non-small cell Lung carcinomas detected on screening chest CT in a high-risk population.
- CT screening for Lung cancer: five-year prospective experience.
- Screening for Lung cancer: current status and future directions: Thomas A. Neff lecture.
- Clinical problem-solving. Occam's razor versus Saint's Triad.
- Computed tomographic screening for Lung cancer: home run or foul ball?
- Lung cancer screening with CT: Mayo Clinic experience.
- Diagnostic approach to the patient with diffuse Lung disease.
- Flexible bronchoscopic management of airway foreign bodies in children.
- Screening for Lung cancer with low-dose spiral computed tomography.
- Clinical strategies for solitary Pulmonary nodule.
- Outpatient care of COPD patients.
- Transmembrane signaling during natural killer cell-mediated cytotoxicity. Regulation by protein kinase C activation.
- Reduced work of breathing after single Lung transplantation for emphysema.
- Reduced work of breathing following single Lung transplantation for emphysema.
- Evolving strategies in Lung transplantation for emphysema.
- Approach to the solitary Pulmonary nodule.
- 30-year-old man with recurrent episodes of dyspnea.
- Lung nodule enhancement at CT: prospective findings.
- Lung transplantation: selection of patients and analysis of outcome.
- Posttransplantation physiologic features of the lung and obliterative Bronchiolitis.
- Medical management and complications in the Lung transplant recipient.
- Endobronchial techniques in Lung cancer. Options for nonsurgical care.
- Chemotherapy for advanced Lung cancer. When to expect a response.
- Native Lung complications after single Lung transplantation for emphysema.
- Indications for flexible versus rigid bronchoscopy in children with suspected foreign-body aspiration.
- p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell Lung cancer.
- Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell Lung cancer.
- Suspected non-small cell Lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.
- Alpha1-antitrypsin deficiency allele carriers among Lung cancer patients.
- Lung nodule enhancement at CT: multicenter study.
- Lung nodules: dual-kilovolt peak analysis with CT--multicenter study.
- Churg-Strauss syndrome complicated by eosinophilic endomyocarditis.
- Solitary Pulmonary nodule: time to think small.
- Nonspecific Interstitial pneumonia: variable appearance at high-resolution chest CT.
- Evaluation of patients with Pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).
- Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell Lung carcinoma.
- Does marital status impact survival and quality of life in patients with non-small cell Lung cancer? Observations from the mayo clinic Lung cancer cohort.
- Caution: screening for Lung cancer.
- Early diagnosis of Lung cancer.
Schools
University Of Minnesota Medical School
Mayo Grad School Med
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Awards
- Fellow (FACP)
Education
-
Mayo School of Graduate Medical Education -
University of Minnesota Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1841270238 | |
| NPPES Provider LastName | MIDTHUN | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 155.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841270238 |
| Last Name Of The Provider | MIDTHUN |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Ulrich Specks, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. McDougall, MD |
|
|
Dr. James P. Utz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter C. Gay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce A. Staats, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. W M. Brutinel, MD |
|
|
Dr. Michael E. Wilson, MD
This Doctor is OpenDoctor Recommended.
|